Consistent with our hypothesis, the subcutaneous xenograft tumors with FGF9 overexpression in nude mice exhibited an aggressive growth pattern of tumor nodules, and these changes were significantly suppressed upon XAV‐939 administration, as shown by the decreased tumor volume and weight (Figure 8A–D). The gene discussed is FGF9; the disease is neoplasm.